1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Locally Advanced Soft Tissue Sarcoma: new trials by email Literature Review of Locally Advanced Soft Tissue Sarcoma trials Research Report on Locally Advanced Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas Lurbinectedin, Radiotherapy, Non-investigational surgery - Locally Advanced Soft Tissue Sarcoma | Phase 1 / Phase 2 | Withdrawn | University of California, San Francisco | 2024-10-31 | 2024-11-18 | |
| First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma CEB-01 membrane loaded with SN-38 - Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma | Phase 1 | Completed | CEBIOTEX | 21 | 2020-06-03 | 2026-05-12 |
| Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas Sirolimus Albumin-bound Nanoparticles, Pazopanib hydrochloride - Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | University of Washington | 19 | 2019-04-01 | 2025-04-30 |
Sarcoma (2) · Recurrence (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective and Soft Tissue (2) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Irinotecan (1) · PM 01183 (1) · Radiotherapy (1) · pazopanib (1)
CEBIOTEX (1) · University of California, San Francisco (1) · University of Washington (1)
Spain (1) · United States (1)
Ana Sebio, M.D. Ph.D. (1) · Lee Cranmer, MD (1) · Varun Monga, MD (1)
PMID 41984420, PMID 41984421, PMID 41998462
2018 (1)